The World Health Organization’s (WHO) technical advisory group on Tuesday sought “additional clarification” from Bharat Biotech for its COVID-19 vaccine Covaxin, to conduct a final “risk-benefit assessment” to list the emergency use of the vaccine.
Watch the video to find out more.
.